Long-Term Liabilities: The sum of all non-current liabilities.
Virax Biolabs Group Limited (VRAX) had Long-Term Liabilities of $0.33M for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$8.03M |
|
$1.05M |
|
$1.41M |
|
$9.44M |
|
$0.69M |
|
-- |
|
|
Long-Term Liabilities |
$0.33M |
$1.03M |
|
$8.42M |
|
$8.42M |
|
$8.42M |
|
4.34M |
|
| Cash Flow Statement Financials | |
$-1.92M |
|
$-0.25M |
|
$5.86M |
|
$3.59M |
|
$7.29M |
|
$3.70M |
|
$0.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|